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Here, we have used the tyrosine kinase inhibitors, erbstatin and genistein, to investigate the potential role of tyrosine kinase activation in the induction of COX-2 and iNOS caused by endotoxin (lipopolysaccharide; LPS at 1 l.tg/ml for 24 h) in bovine aortic endothelial cells (BAEC) and J774.2 macrophages. The predominant COX metabolites, 6-oxo-prostaglandin (PG) Flu (for BAEC) and PGF2= (for 774.2 macrophages) were measured by radioimmunoassay under the following experimental conditions: (i) accumulation of COX metabolites from endogenous arachidonic acid was measured at 24 h after addition of LPS (1 lag/ml); (ii) in experiments designed to measure 'COX activity', COX metabolites generated by LPS-activated BAEC or J774.2 macrophages were assayed after incubation with exogenous arachidonic acid (30 l.tM for 15 min). Western blot analysis with a specific antibody to COX-2 was used to determine the expression of COX-2 protein caused by LPS in cell extracts. Accumulation of nitrite (measured by the Griess reaction) was used to measure NOS activity. Erbstatin (0.05-5 l.tg/ml) or genistein (0.5-50 btg/ml) caused a dose-dependent inhibition of the accumulation of COX metabolites in the supernatant of LPS-activated BAEC or J774.2 macrophages.
Erbstatin or genistein also caused a dose-dependent inhibition of 'COX activity' in both cell types. Western blot analysis showed that erbstatin (5 btg/ml) or genistein (50 l.tg/ml) inhibited Inhibition of the local Shwartzman reaction in rabbits by CSVTCG, a thrombospondin-derived hexapeptide Thrombospondin (TSP) is a multidomain protein involved in cell adhesion processes through its associations with CD36 (GPIV, GPIIIb), zfl3, {41, and perhaps other binding proteins. The CSVTCG motif in TSP is responsible for TSP binding to CD36, and is reported to mediate tumour cell adhesion and platelet aggregation. The peptide form of CSVTCG blocks TSP-induced cell-cell associations. We were interested in determining whether this peptide might reduce microvascular pathophysiology, and thus tested it in a model of dermal thrombo-haemorrhage, the local Shwartzman reaction (LSR), in rabbits. The LSR was produced by intradermal injection of endotoxin (preparative dose) followed by intravenous administration of endotoxin (provocative dose) 18-24 h later. Haemorrhagic lesions that developed in the prepared skin sites were quantified by nlln-labelled erythrocytes.. CSVTCG, at a dose of 1.0 mg/kg, given i.v. 15 min before the provocative dose induced a dose-dependent inhibition of haemorrhage (max. 80%,.p < 0.05). The same dose of CSVTCG given i.v. 15 min before the preparatory dose was less effective and, when given i.d., had no effect on haemorrhage. 
